Benoquin is a topical prescription drug approved by the U.S. Food and Drug Administration (FDA) for removing pigment in people with vitiligo that covers more than 50 percent of their body. 1,2 The skin bleaching effects of Benoquin are permanent and irreversible.

Hydrochlorothiazide is a diuretic which lowers blood pressure by removing extra water and certain electrolytes from the body. Over time it also relaxes blood vessels and improves blood flow.

A multi-functional targeted treatment, that brightens, hydrates, and smoothes fine lines while protecting the skin from stress and fatigue. Reduces hyperpigmentation and blemishes.

Using a Vitamin C toner can help in reducing the look of uneven skin tone, which leaves it appearing more balanced and radiant. It does this by inhibiting melanin production which is responsible for pigmentation that causes dark spots hence giving a uniform complexion.

Aziderm-20% Gel is utilised primarily in managing mild to moderate acne. This medicine is part of a class of medications known as dicarboxylic acids. In addition to helping reduce acne symptoms such as pimples, lumps, redness, and swelling, this can also aid in preventing hyperpigmentation.

Ethiglo tablet contains alpha lipoic acid and L-glutathione that is used for skin whitening. It reduces pigmentation, dark spots, acne scar, wrinkles, blemishes, tan and freckles. Also, it helps to soften, smoothen, nourish and brighten the skin.Boosts Skin Radiance and Brightness: Skin Glow Capsules contain Lycopene, Curcumin, and Resveratrol, potent antioxidants that fight free radicals, reduce pigmentation, and promote a bright, even complexion.

Benoquin Cream 20% is indicated for final depigmentation in extensive Vitiligo. Benoquin Cream 20% is applied topically to permanently depigment normal skin surrounding vitiliginous lesions in patients with disseminated (greater than 50 percent of body surface area) idiopathic vitiligo.

Benoquin Cream 20% is indicated for final depigmentation in extensive Vitiligo. Benoquin Cream 20% is applied topically to permanently depigment normal skin surrounding vitiliginous lesions in patients with disseminated (greater than 50 percent of body surface area) idiopathic vitiligo.

Tranexamic acid gel, particularly Tranesma 5% gel, is categorized as an antifibrinolytic agent. It works by preventing the breakdown of blood clots, thereby helping to control or stop bleeding. The gel formulation may also be used for its potential benefits in dermatology, such as treating melasma and hyperpigmentation.